Envista NVST Stock
Envista Price Chart
Envista NVST Financial and Trading Overview
Envista stock price | 19.18 USD |
Previous Close | 31.53 USD |
Open | 31.59 USD |
Bid | 30.64 USD x 800 |
Ask | 35.97 USD x 1000 |
Day's Range | 31.34 - 32.69 USD |
52 Week Range | 31.2 - 43.29 USD |
Volume | 2.61M USD |
Avg. Volume | 2.06M USD |
Market Cap | 5.34B USD |
Beta (5Y Monthly) | 1.430551 |
PE Ratio (TTM) | 26.528456 |
EPS (TTM) | -0.6 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 44.5 USD |
NVST Valuation Measures
Enterprise Value | 6.29B USD |
Trailing P/E | 26.528456 |
Forward P/E | 15.319248 |
PEG Ratio (5 yr expected) | 1.61 |
Price/Sales (ttm) | 2.0825748 |
Price/Book (mrq) | 1.2483263 |
Enterprise Value/Revenue | 2.453 |
Enterprise Value/EBITDA | 12.872 |
Trading Information
Envista Stock Price History
Beta (5Y Monthly) | 1.430551 |
52-Week Change | -8.31% |
S&P500 52-Week Change | 20.43% |
52 Week High | 43.29 USD |
52 Week Low | 31.2 USD |
50-Day Moving Average | 35.43 USD |
200-Day Moving Average | 35.87 USD |
NVST Share Statistics
Avg. Volume (3 month) | 2.06M USD |
Avg. Daily Volume (10-Days) | 2.17M USD |
Shares Outstanding | 163.7M |
Float | 163.16M |
Short Ratio | 4.74 |
% Held by Insiders | 0.33% |
% Held by Institutions | 115.61% |
Shares Short | 11.36M |
Short % of Float | 7.83% |
Short % of Shares Outstanding | 6.94% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 8.26% |
Operating Margin (ttm) | 13.48% |
Gross Margin | 57.83% |
EBITDA Margin | 19.05% |
Management Effectiveness
Return on Assets (ttm) | 3.28% |
Return on Equity (ttm) | 5.08% |
Income Statement
Revenue (ttm) | 2.56B USD |
Revenue Per Share (ttm) | 15.71 USD |
Quarterly Revenue Growth (yoy) | -0.70% |
Gross Profit (ttm) | 1.49B USD |
EBITDA | 488.7M USD |
Net Income Avi to Common (ttm) | 211.4M USD |
Diluted EPS (ttm) | 1.23 |
Quarterly Earnings Growth (yoy) | -41.50% |
Balance Sheet
Total Cash (mrq) | 585.2M USD |
Total Cash Per Share (mrq) | 3.58 USD |
Total Debt (mrq) | 1.53B USD |
Total Debt/Equity (mrq) | 35.86 USD |
Current Ratio (mrq) | 1.23 |
Book Value Per Share (mrq) | 26.139 |
Cash Flow Statement
Operating Cash Flow (ttm) | 182.3M USD |
Levered Free Cash Flow (ttm) | 209.28M USD |
Profile of Envista
Country | United States |
State | CA |
City | Brea |
Address | Building E |
ZIP | 92821-6208 |
Phone | 714 817 7000 |
Website | https://envistaco.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 12700 |
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Q&A For Envista Stock
What is a current NVST stock price?
Envista NVST stock price today per share is 19.18 USD.
How to purchase Envista stock?
You can buy NVST shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Envista?
The stock symbol or ticker of Envista is NVST.
Which industry does the Envista company belong to?
The Envista industry is Medical Instruments & Supplies.
How many shares does Envista have in circulation?
The max supply of Envista shares is 171.86M.
What is Envista Price to Earnings Ratio (PE Ratio)?
Envista PE Ratio is now.
What was Envista earnings per share over the trailing 12 months (TTM)?
Envista EPS is -0.6 USD over the trailing 12 months.
Which sector does the Envista company belong to?
The Envista sector is Healthcare.
Envista NVST included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
- {{ link.label }} {{link}}